Drug Shortage Report for HAVRIX 1440
| Report ID | 254935 |
| Drug Identification Number | 02187078 |
| Brand name | HAVRIX 1440 |
| Common or Proper name | hepatitis A vaccine, inactivated |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS A VIRUS, INACTIVATED |
| Strength(s) | 1440UNIT |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1's (prefilled syringe / seringue préremplie) |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-04-09 |
| Estimated end date | 2025-05-16 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-02 |
| Company comments | Doses reserved for Public programs, supply disruptions may be seen in the private market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-05-02 | French | Compare |
| v3 | 2025-05-02 | English | Compare |
| v2 | 2025-04-11 | French | Compare |
| v1 | 2025-04-11 | English | Compare |
Showing 1 to 4 of 4